These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26945922)

  • 1. Postmortem validation of MRI cortical volume measurements in MS.
    Popescu V; Klaver R; Versteeg A; Voorn P; Twisk JW; Barkhof F; Geurts JJ; Vrenken H
    Hum Brain Mapp; 2016 Jun; 37(6):2223-33. PubMed ID: 26945922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.
    Vidal-Jordana A; Pareto D; Sastre-Garriga J; Auger C; Ciampi E; Montalban X; Rovira A
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):250-256. PubMed ID: 27884876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?
    Rajagopalan V; Pioro EP
    BMC Neurol; 2015 Mar; 15():32. PubMed ID: 25879588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
    Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
    J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
    PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
    Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
    Battaglini M; Jenkinson M; De Stefano N;
    Hum Brain Mapp; 2018 Mar; 39(3):1063-1077. PubMed ID: 29222814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients.
    Righart R; Schmidt P; Dahnke R; Biberacher V; Beer A; Buck D; Hemmer B; Kirschke JS; Zimmer C; Gaser C; Mühlau M
    PLoS One; 2017; 12(7):e0179590. PubMed ID: 28683072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths.
    Heinen R; Bouvy WH; Mendrik AM; Viergever MA; Biessels GJ; de Bresser J
    PLoS One; 2016; 11(10):e0165719. PubMed ID: 27798694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
    Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
    Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
    Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
    Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
    Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.